LRMR: Larimar Therapeutics Inc Price Chart

Larimar Therapeutics (LRMR) relies on US-based R&D centers while outsourcing the production of peptide agents to external contractors. The company develops therapies for orphan brain pathologies, securing exclusive sales rights through patents. The price action of the securities is fixed at 3.01. High trust from patient communities and positive dynamics in the trials of the Friedreich's ataxia drug strengthen the developer's position.

Stock Quotes: Larimar Therapeutics (LRMR) for 07/04/2022 - 11/14/2026

Larimar Pharma - analytical breakdowns and key metrics (LRMR)

- stock value and consensus price forecast:

Price Chart Larimar Therapeutics, Inc.|LRMR - Price Target Chart

- market capitalization information:

Market Value Larimar Therapeutics|LRMR - Value Adjusted for Debt and Cash

- balance sheet equity data:

Net Assets per Single Share Larimar Therapeutics|LRMR - Company Net Assets|Market Value to Book Value Ratio larimartx.com|LRMR - Aggregate Asset Value

- debt burden and liquidity indicators:

- company profitability and valuation multiples indicators:

LRMR - Net Income|Projected Future Earnings Larimar Therapeutics|LRMR - P/E Multiple|Projected Price to Earnings Larimar Pharma|LRMR - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Larimar Therapeutics, Inc.|LRMR - Operating profit before amortization|Net earnings per share (EPS TTM) Larimar Therapeutics|LRMR - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months larimartx.com|LRMR - Earnings growth in current year|Net earnings per share growth forecast for next year Larimar Therapeutics

- total revenue and sales volume data:

LRMR - Company Sales Revenue|Company Projected Revenue Larimar Corp|LRMR - Price to Sales|Price-to-Projected Revenue Ratio Larimar Corp

Fundamental valuation:larimartx.com

Signature product of Larimar Therapeutics Inc

Monitoring the market value of an asset—calculated as the sum of closing trades to reflect the current investor consensus on company equity—is critical for constructing a defensive portfolio. In the case of Larimar Therapeutics (LRMR), the price trajectory visualizes the market reaction to raw material supply chain disruption risks and the complexities of international clinical trials, determining the final balance of supply and demand.

LRMR: Larimar Therapeutics Inc Price Chart

Larimar Pharma - analytical breakdowns and key metrics (LRMR)

Analysis of competing companies